4: Statement of changes in beneficial ownership of securities-Officer Reardon Andrew
4: Statement of changes in beneficial ownership of securities-Officer Espinoza Octavio
4: Statement of changes in beneficial ownership of securities-Officer Korenberg Matthew E
144: Notice of proposed sale of securities pursuant to Rule 144
144: Notice of proposed sale of securities pursuant to Rule 144
144: Notice of proposed sale of securities pursuant to Rule 144
144: Notice of proposed sale of securities pursuant to Rule 144
4: Statement of changes in beneficial ownership of securities-Officer Espinoza Octavio
4: Statement of changes in beneficial ownership of securities-Officer Korenberg Matthew E
4: Statement of changes in beneficial ownership of securities-Officer Espinoza Octavio
4: Statement of changes in beneficial ownership of securities-Officer Reardon Andrew
144: Notice of proposed sale of securities pursuant to Rule 144
4: Statement of changes in beneficial ownership of securities-Officer Korenberg Matthew E
144: Notice of proposed sale of securities pursuant to Rule 144
4: Statement of changes in beneficial ownership of securities-Officer Korenberg Matthew E
4: Statement of changes in beneficial ownership of securities-Officer Davis Todd C
144: Notice of proposed sale of securities pursuant to Rule 144
10-Q: Q2 2024 Earnings Report
8-K: Ligand Reports Second Quarter 2024 Financial Results
8-K: Current report
No Data
No Data